Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Targeting Myelin NEFA in PAR1 and PAR2 Mice after SCI

ABSTRACT:

ORGANISM(S): Mus Musculus

TISSUE(S): Spinal Cord

DISEASE(S): Spinal Cord Injury

PROVIDER: ST000861 | MetabolomicsWorkbench |

REPOSITORIES: MetabolomicsWorkbench

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	mwtab	Other

Items per page:

1 - 1 of 1

Similar Datasets

Targeting microvasculature for neuroprotection after SCI.

Project description: Not available

| S-EPMC3101824 | biostudies-literature

Targeting Myelin Ceramides in PAR1 and PAR2 Mice after SCI

Project description: Not available

| ST000864 | MetabolomicsWorkbench

Targeted NEFA in Kallikrein 6 Mice after SCI

Project description: Not available

| ST000856 | MetabolomicsWorkbench

Targeting Myelin FFA Compostion in PAR1 and PAR2 Mice after SCI

Project description: Not available

| ST000862 | MetabolomicsWorkbench

Targeting Myelin Cholesterol in PAR1 and PAR2 Mice after SCI

Project description: Not available

| ST000863 | MetabolomicsWorkbench

Targeted NEFA Panel of Myelin to Enhance Recovery of Function after SCI

Project description: Not available

| ST000794 | MetabolomicsWorkbench

miRQC PGM data

Project description:MicroRNAs are important negative regulators of protein coding gene expression, and have been studied intensively over the last few years. To this purpose, different measurement platforms to determine their RNA abundance levels in biological samples have been developed. In this study, we have systematically compared 12 commercially available microRNA expression platforms by measuring an identical set of 20 standardized positive and negative control samples, including human universal reference RNA, human brain RNA and titrations thereof, human serum samples, and synthetic spikes from homologous microRNA family members. We developed novel quality metrics in order to objectively assess platform performance of very different technologies such as small RNA sequencing, RT-qPCR and (microarray) hybridization. We assessed reproducibility, sensitivity, quantitative performance, and specificity. The results indicate that each method has its strengths and weaknesses, which helps guiding informed selection of a quantitative microRNA gene expression platform in function of particular study goals.

2013-09-01 | E-MTAB-1815 | biostudies-arrayexpress

Increased NEFA levels reduce blood Mg<sup>2+</sup> in hypertriacylglycerolaemic states via direct binding of NEFA to Mg<sup>2</sup>.

Project description: Not available

| S-EPMC6323097 | biostudies-literature

Myelin regeneration in multiple sclerosis: targeting endogenous stem cells.

Project description: Not available

| S-EPMC3250284 | biostudies-literature

RNA sequencing from planarian tissues

Project description:The aim of the experiment was to compare the transcriptome of intact control and prep knock down animals.

2026-02-01 | E-MTAB-14438 | biostudies-arrayexpress